<DOC>
	<DOCNO>NCT00110461</DOCNO>
	<brief_summary>The purpose trial test safety efficacy two dos aripiprazole child adolescent patient bipolar I disorder , manic mixed episode without psychotic feature .</brief_summary>
	<brief_title>Aripiprazole Children Adolescents With Bipolar I Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Child adolescent patient bipolar I disorder , manic mixed episode without psychotic feature Patients certain psychological disorder Patients comorbid serious , uncontrolled systemic illness Patients significant risk commit suicide</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Aripiprazole</keyword>
	<keyword>Bipolar I Disorder , Manic Mixed Episode without Psychotic Features</keyword>
</DOC>